Bosnia's Solidarity Fund drug list unchanged for 7 years, patients miss therapies

Patients in the Federation of Bosnia and Herzegovina have waited seven years for a revision of the Solidarity Fund's drug list, delaying access to modern treatments. The delay reflects systemic underfunding and bureaucratic inertia, with no clear timeline for reform. This highlights a chronic healthcare access gap in the region.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works